Characterization of Extremely Drug-Resistant and Hypervirulent <i>Acinetobacter baumannii</i> AB030

Characterization of Extremely Drug-Resistant and Hypervirulent <i>Acinetobacter baumannii</i> AB030

<i>Acinetobacter baumannii</i> is an important nosocomial bacterial pathogen. Multidrug-resistant isolates of <i>A. baumannii</i> are reported worldwide. Some <i>A. baumannii</i> isolates display resistance to nearly all antibiotics, making treatment of infections...

Full description

Bibliographic Details
Main Authors:	Manu Singh, P. Malaka De Silva, Yasser Al-Saadi, Jacek Switala, Peter C. Loewen, Georg Hausner, Wangxue Chen, Ismael Hernandez, Santiago Castillo-Ramirez, Ayush Kumar
Format:	Article
Language:	English
Published:	MDPI AG 2020-06-01
Series:	Antibiotics
Subjects:	multidrug resistance virulence gram-negative comparative genomics insertion elements
Online Access:	https://www.mdpi.com/2079-6382/9/6/328

Similar Items

Factors influencing survival in patients with multidrug-resistant Acinetobacter baumannii infection
by: Mariana Lima Prata-Rocha, et al.

In Vitro Activities of Colistin and Sitafloxacin Combinations against Multidrug-, Carbapenem-, and Colistin-Resistant <i>Acinetobacter baumannii</i> Using the Broth Microdilution Checkerboard and Time-Kill Methods
by: Vipavee Rodjun, et al.
Published: (2020-08-01)

Colistin Dependence in Extensively Drug-Resistant <i>Acinetobacter baumannii</i> Strain Is Associated with IS<i>Ajo2</i> and IS<i>Aba13</i> Insertions and Multiple Cellular Responses
by: Sherley Chamoun, et al.
Published: (2021-01-01)

Analysis of <i>bla</i><sub>CHDL</sub> Genes and Insertion Sequences Related to Carbapenem Resistance in <i>Acinetobacter baumannii</i> Clinical Strains Isolated in Warsaw, Poland
by: Alicja Słoczyńska, et al.
Published: (2021-03-01)

Efflux-Related Carbapenem Resistance in <i>Acinetobacter baumannii</i> Is Associated with Two-Component Regulatory Efflux Systems’ Alteration and Insertion of ΔAbaR25-Type Island Fragment
by: Alicja Słoczyńska, et al.
Published: (2023-05-01)

<i>Acinetobacter baumannii</i> Antibiotic Resistance Mechanisms
by: Ioannis Kyriakidis, et al.
Published: (2021-03-01)

In Vivo Evaluation of ECP Peptide Analogues for the Treatment of <i>Acinetobacter baumannii</i> Infection
by: Jiarui Li, et al.
Published: (2022-02-01)

In vitro and in vivo assessment of the antibacterial activity of colistin alone and in combination with other antibiotics against Acinetobacter baumannii and Escherichia coli
by: Yale Wang, et al.
Published: (2020-03-01)

Biological Properties of 12 Newly Isolated <i>Acinetobacter baumannii</i>-Specific Bacteriophages
by: Natalia Bagińska, et al.
Published: (2023-01-01)

A Nosocomial Gram Negative Meningitis Caused By Acinetobacter SPP: Case Report
by: Taj ML Atri A, et al.
Published: (2003-08-01)

Antibiotic Resistance and Genotypes of Nosocomial Strains of <i>Acinetobacter baumannii</i> in Kazakhstan
by: Alyona Lavrinenko, et al.
Published: (2021-04-01)

The Mechanism of Tigecycline Resistance in <i>Acinetobacter baumannii</i> Revealed by Proteomic and Genomic Analysis
by: Cunwei Liu, et al.
Published: (2023-05-01)

Novel Phage Lysin Abp013 against <i>Acinetobacter baumannii</i>
by: Joash Jun Keat Chu, et al.
Published: (2022-01-01)

Host Innate Immune Responses to Acinetobacter baumannii Infection
by: Wangxue Chen, et al.
Published: (2020-09-01)

Gram-Negative Bacteria Holding Together in a Biofilm: The <i>Acinetobacter baumannii</i> Way
by: Arianna Pompilio, et al.
Published: (2021-06-01)

A Novel Acinetobacter baumannii Bacteriophage Endolysin LysAB54 With High Antibacterial Activity Against Multiple Gram-Negative Microbes
by: Fazal Mehmood Khan, et al.
Published: (2021-03-01)

PYED-1 Overcomes Colistin Resistance in <i>Acinetobacter baumannii</i>
by: Maria Stabile, et al.
Published: (2023-11-01)

Genomic Diversity, Antimicrobial Susceptibility, and Biofilm Formation of Clinical <i>Acinetobacter baumannii</i> Isolates from Horses
by: Johanna Rühl-Teichner, et al.
Published: (2023-02-01)

Multidrug-Resistant Acinetobacter baumannii
by: Aharon Abbo, et al.
Published: (2005-01-01)

Multidrug-resistant Acinetobacter baumannii, Russia
by: Thierry Naas, et al.
Published: (2007-04-01)

The Antimicrobial Peptide Octopromycin Suppresses Biofilm Formation and Quorum Sensing in <i>Acinetobacter baumannii</i>
by: Dinusha Chathurangi Rajapaksha, et al.
Published: (2023-03-01)

Durlobactam in the Treatment of Multidrug-Resistant <i>Acinetobacter baumannii</i> Infections: A Systematic Review
by: Guido Granata, et al.
Published: (2022-06-01)

Virulence Characteristics and Emerging Therapies for Biofilm-Forming <i>Acinetobacter baumannii</i>: A Review
by: Karma G. Dolma, et al.
Published: (2022-09-01)

Is It Possible to Eradicate Carbapenem-Resistant <i>Acinetobacter baumannii</i> (CRAB) from Endemic Hospitals?
by: Filippo Medioli, et al.
Published: (2022-07-01)

Evaluation of DNA Extraction Methods for Reliable Quantification of <i>Acinetobacter baumannii</i>, <i>Klebsiella pneumoniae</i>, and <i>Pseudomonas aeruginosa</i>
by: Alexandra Bogožalec Košir, et al.
Published: (2023-04-01)

Virulence Potential and Treatment Options of Multidrug-Resistant (MDR) <i>Acinetobacter baumannii</i>
by: Sunil Kumar, et al.
Published: (2021-10-01)

Isolation of bacteriophages against multidrug resistant Acinetobacter baumannii
by: Hasan Ghajavand, et al.
Published: (2017-01-01)

Recent Progress in Phage Therapy to Modulate Multidrug-Resistant <i>Acinetobacter baumannii</i>, including in Human and Poultry
by: Yan Zhang, et al.
Published: (2022-10-01)

The effect of chlorhexidine on Acinetobacter baumannii in intensive care units
by: Michel F. Martinez-Resendez, et al.
Published: (2022-02-01)

Mechanisms Underlying Synergistic Killing of Polymyxin B in Combination with Cannabidiol against <i>Acinetobacter baumannii</i>: A Metabolomic Study
by: Maytham Hussein, et al.
Published: (2022-04-01)

Novel Antimicrobial Peptide “Octoprohibitin” against Multidrug Resistant <i>Acinetobacter baumannii</i>
by: E. H. T. Thulshan Jayathilaka, et al.
Published: (2022-07-01)

In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Jacinda C. Abdul-Mutakabbir, et al.
Published: (2021-07-01)

Polyclonal spread of blaOXA-23 and blaOXA-58 in Acinetobacter baumannii isolates from Argentina
by: Andrea Karina Merkier,1 Mariana Catalano,1 María Soledad Ramírez,1 Cecilia Quiroga,1 Betina Orman,1 Laura Ratier,1 Angela Famiglietti,2 Carlos Vay,2 Ana Di Martino,3 Sara Kaufman,4 Daniela Centrón.1
Published: (2008-06-01)

Multidrug-Resistant Acinetobacter baumannii Osteomyelitis from Iraq
by: Jason J. Schafer, et al.
Published: (2008-03-01)

In Vitro Activity of Cefiderocol against a Global Collection of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Isolates
by: Harald Seifert, et al.
Published: (2023-07-01)

Phenotypic and Genotypic Investigation of Carbapenem-Resistant <i>Acinetobacter baumannii</i> in Maharaj Nakhon Si Thammarat Hospital, Thailand
by: Sirijan Santajit, et al.
Published: (2023-03-01)

Computationally Designed AMPs with Antibacterial and Antibiofilm Activity against MDR <i>Acinetobacter baumannii</i>
by: Fahad M. Alsaab, et al.
Published: (2023-09-01)

Antimicrobial resistance patterns of Acinetobacter baumannii colonization patients skin
by: Aza Bahadeen Taha
Published: (2020-04-01)

Multidrug-resistant Acinetobacter baumannii outbreaks: a global problem in healthcare settings
by: Mariana Neri Lucas Kurihara, et al.
Published: (2020-11-01)

Effect of Subinhibitory Concentrations of Antibiotics and Disinfectants on IS<i>Aba</i>-Mediated Inactivation of Lipooligosaccharide Biosynthesis Genes in <i>Acinetobacter baumannii</i>
by: Héctor Olmeda-López, et al.
Published: (2021-10-01)